Literature DB >> 3409203

Dietary iron enhances the tumor rate in dimethylhydrazine-induced colon carcinogenesis in mice.

C P Siegers1, D Bumann, G Baretton, M Younes.   

Abstract

Treatment of male mice with 20 mg/kg dimethylhydrazine (DMH) s.c. for 10 weeks caused a mean tumour rate of 3.5 after 20 weeks. Dietary iron (3.5% Fefumarate for 10 weeks) enhanced the mean tumour rate to 13.9. All tumours detected were localized exclusively in the distal colon and rectum. The iron load caused a 6.5-fold increase in the mucosal Fe-concentration in the proximal as well as distal colon. DMH-demethylase activity was not influenced by iron and did not differ between proximal and distal segments. Cytosolic alcohol dehydrogenase (ADH) activity was also not altered by iron, but was 3.3-fold higher in the distal colon and rectum as compared to proximal segments; this might explain the DMH-induced tumorigenesis in the distal colon only. It is suggested that iron ions might evoke cocarcinogenic activity by a stimulation of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409203     DOI: 10.1016/0304-3835(88)90285-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Serum ferritin levels and transferrin saturation in men with prostate cancer.

Authors:  Solo R Kuvibidila; Tony Gauthier; Walter Rayford
Journal:  J Natl Med Assoc       Date:  2004-05       Impact factor: 1.798

2.  Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Amanda J Cross; Rashmi Sinha; Richard J Wood; Xiaonan Xue; Wen-Yi Huang; Meredith Yeager; Richard B Hayes; Marc J Gunter
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-17

3.  Generation of reactive oxygen species by the faecal matrix.

Authors:  R W Owen; B Spiegelhalder; H Bartsch
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 4.  Association of iron with colorectal cancer.

Authors:  E D Weinberg
Journal:  Biometals       Date:  1994-07       Impact factor: 2.949

5.  An iron regulatory gene signature predicts outcome in breast cancer.

Authors:  Lance D Miller; Lan G Coffman; Jeff W Chou; Michael A Black; Jonas Bergh; Ralph D'Agostino; Suzy V Torti; Frank M Torti
Journal:  Cancer Res       Date:  2011-08-29       Impact factor: 12.701

6.  Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis.

Authors:  Xiang Xue; Matthew Taylor; Erik Anderson; Cathy Hao; Aijuan Qu; Joel K Greenson; Ellen M Zimmermann; Frank J Gonzalez; Yatrik M Shah
Journal:  Cancer Res       Date:  2012-03-14       Impact factor: 12.701

7.  Faecal phytic acid and its relation to other putative markers of risk for colorectal cancer.

Authors:  R W Owen; U M Weisgerber; B Spiegelhalder; H Bartsch
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

8.  Dietary and stored iron as predictors of breast cancer risk: A nested case-control study in Shanghai.

Authors:  Amber B Moore; Jackilen Shannon; Chu Chen; Johanna W Lampe; Roberta M Ray; Sharon K Lewis; Minggang Lin; Helge Stalsberg; David B Thomas
Journal:  Int J Cancer       Date:  2009-09-01       Impact factor: 7.396

Review 9.  Roles of iron in neoplasia. Promotion, prevention, and therapy.

Authors:  E D Weinberg
Journal:  Biol Trace Elem Res       Date:  1992-08       Impact factor: 3.738

10.  Proton-Induced X-ray Emission (PIXE) Analysis and DNA-chain Break study in rat hepatocarcinogenesis: A possible chemopreventive role by combined supplementation of vanadium and beta-carotene.

Authors:  Mitali Basu Chattopadhyay; Sutapa Mukherjee; Indira Kulkarni; V Vijayan; Manika Doloi; Nb Kanjilal; Malay Chatterjee
Journal:  Cancer Cell Int       Date:  2005-05-26       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.